Glofit and Obin in Follicular Lymphoma and Marginal Zone Lymphoma

NCT05783596 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

47

Enrollment

OTHER

Sponsor class

Conditions

Follicular Lymphoma
Marginal Zone Lymphoma
Indolent Non-hodgkin Lymphoma

Interventions

DRUG: Obinutuzumab
DRUG: Glofitamab

Sponsor

Reid Merryman, MD

Collaborators

[object Object]